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C4bp, a regulator of the classical pathway of complement system, is composed of 6-8 disulfide-linked 
subunit chains of 75 kDa. Upon incubation with chymotrypsin, C4bp was rapidly cleaved into a nicked 
C4bp, composed of disulfide-linked 48 kDa and 27 kDa fragments. Subsequent slow cleavage on the 
27 kDa fragment resulted in the liberation of the active site-containing 48 kDa fragment from the nicked 
C4bp. The N-terminal amino acid sequence of the 48 kDa fragment was identical to that of the parent 
subunit chain of C4bp, indicating that the 48 kDa active fragment was released from the N-terminal side 
of the parent subunit chain. Based on these results, a possible gross structure of C4bp is proposed. 
C4b-binding protein Active fragment 
1. INTRODUCTION 
C4b-binding protein, C4bp, is an important 
regulator of the C3 convertase, C4b,2a, of the 
classical pathway of complement system; it acts as 
a cofactor for the cleavage of C4b by C3b inac- 
tivator [l-3] and also acts as the decay-accelerator 
of the C3 convertase [4]. 
C4bp is known to be composed of 6-8 disulfide- 
linked polypeptide chains of 70-75 kDa [5-g]. 
Previously, we reported that chymotrypsin 
liberated a 48 kDa fragment having the cofactor 
activity from each subunit chain of C4bp and pro- 
duced a 180 kDa core fragment composed of 
disulfide-linked 25 kDa fragments [lo]. 
The authors in [l l] examined the gross structure 
Abbreviations: C4bp, C4b-binding protein; 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel 
electrophoresis; DFP, diisopropyl fluorophosphate; 
PTH, phenylthiohydantoin; HPLC, high-performance 
liquid chromatography; DTT, dithiothreitol 
Limited proteolysis Subunit chain structure 
of C4bp by electron microscopy and obtained 
evidence suggesting that C4bp has a spider-like 
structure and is composed of 7 thin, elongated, 
and flexible subunits that are linked to a small cen- 
tral body and that C4b binds to the peripheral ends 
of each subunit resembling tentacles. 
However, it has remained unclear whether the 
functional domain of C4bp is located in the N- or 
C-terminal side of the subunit chain. So, deter- 
mination of the N-terminal amino acid sequence of 
the 48 kDa active fragment seemed to provide in- 
formation concerning the gross structure of C4bp. 
We here investigate the process of liberation of 
the 48 kDa active fragment from C4bp by 
chymotryptic cleavage and determine the chemical 
nature of the 48 kDa active fragment. Based on 
these results, a possible model of subunit chain 
structure of C4bp is proposed. 
2. MATERIALS AND METHODS 
Human C4bp and its two major chymotryptic 
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fragments, 180 kDa core and 48 kDa active 
fragments, were isolated as in [lo]. SDS-PAGE 
was performed as in [12]. Amino acid analysis was 
performed as in [13]. The N-terminal amino acid 
sequence analysis of the carboxamidomethylated 
48 kDa fragment was performed by automated 
Edman degradation in a JEOL JS-47K Sequence 
analyzer using 0.25 M Quadrol buffer in the 
presence of 3 mg Polybrene [14] and double- 
coupling program at the first step. PTH derivatives 
of amino acids were identified by HPLC in a 
Dupon Zorbax BP-ODS column (4.6 x 250 mm) 
using a Hitachi 655 liquid chromatograph system. 
Isoelectric focusing was performed as in [ 151, using 
5.5% polyacrylamide gels and ampholines of pH 
4-6 for the core fragment and pH 5-9 for the ac- 
tive fragment. Immunoelectrophoresis was per- 
formed using an antiserum against C4bp as in [6]. 
NonreductIon Reductton 
0 10 20 30 60 120 X0 0 10 20 30 60 120 2LO 
INCUBATION TIME b-m) 
3. RESULTS 
3.1. Time course of chymotryptic cleavage of 
Fig.1. Time course of chymotryptic cleavage of C4bp. 
C4bp was incubated with chymotrypsin 
(C4bp/chymotrypsin, 150: 1, w/w) at 37°C for indicated 
periods. Aliquots of the incubation mixture were 
removed, mixed with 2 mM DFP, and subjected to 
SDS-PAGE before and after treatment with 10 mM 
DTT. SDS-PAGE of reduced and nonreduced samples 
were performed with 7.5 and 3.5% polyacrylamide gels, 
respectively. 
C4bp 
C4bp was incubated with chymotrypsin at 37°C 
and samples were periodically taken and subjected 
to SDS-PAGE before and after treatment with 
DTT (fig.1). SDS-PAGE of the unreduced 
samples howed that liberation of the 48 kDa frag- 
ment from C4bp was a slow reaction and became 
apparent after 30 min incubation with chymotryp- 
sin under these conditions. On the other hand, 
SDS-PAGE of reduced samples howed that prior 
to the liberation of the 48 kDa fragment, the 
parent 75 kDa subunit chains were rapidly cleaved 
into two fragments of 48 kDa and 27 kDa and that 
parallel to the liberation of the 48 kDa fragment, 
the cleavage of the 27 kDa fragment into a 25 kDa 
fragment appeared to proceed. These results sug- 
gest that the liberation of the active fragment from 
C4bp by chymotrypsin is a two-step reaction; first- 
ly, rapid cleavage occurs on a loop of the polypep- 
tide chain bridged by a disulfide bond to yield a 
nicked C4bp and secondly, slow cleavage on the 
27 kDa fragment splits the linkage between the two 
fragments and releases the 48 kDa fragment from 
the nicked C4bp. 
Table 1 
Amino acid compositions of the 180 kDa and 48 kDa 
fragments of C4bpa 
Amino acid Residues/ 100 residues 
180 kDa 48 kDa 
Asp 8.6 8.9 
Thr 3.9 7.8 
Ser 5.8 8.6 
GlU 18.2 9.8 
Pro 8.9 9.9 
CfY 7.3 9.8 
Ala 4.5 4.1 
Val 6.9 5.5 
Met 1.7 0.3 
Be 3.5 5.0 
Leu 8.9 4.9 
Tyr 4.0 3.5 
Phe 0.9 4.3 
His 0.7 3.5 
Lys 7.0 5.2 
Arg 3.9 5.4 
Cys/2b 5.5 4.8 
3.2. Characterization of the 48 kDa active 
fragment 
a Samples were hydrolyzed in 5.7 N HCl for 24 h at 
110°C under vacuum. The values are the average of 
triplicate analyses 
Table 1 gives the amino acid composition of the b Half-cystine was estimated as cysteic acid 
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Fig.2. 
Anode was on the left. 
Immunoele~trop~oresis of two major 
chymotryptic fragments of C4bp. The 180 kDa and 
48 kDa fragments were subjected to electrophoresis on 
1% agar gel and diffused against anti-C4bp antiserum. 
48 kDa active fragment and, for comparison, of 
the 180 kDa core fragment. The core fragment is 
rich in Glu, Leu, and Lys, compared to the active 
fragment, while the active fragment is rich in Thr, 
Phe, His, and Arg, in comparison with the core 
fragment. 
Fig.2 shows immunoelectrophoresis of the two 
fragments. The core fragment migrates toward the 
anodal site, while the active fragment migrates 
toward the cathodal site. The isoelectric points of 
Fig.3. A possible model of the subunit chain structure of 
C4bp. C4bp is tentatively shown as a 6-subunit chain 
structure. CT, chymotrypsin; QQ, represents 
carbohydrate chains. Shadow zone and dotted line 
denote the active domain of C4bp and disulfide linkage, 
respectively. 
the core and active fragments were found to be 4.7 
and 7.5, respectively. These results indicate that 
the two domains characteristically differ from each 
other in amino acid composition and surface 
charges. 
Twenty steps of the Edman degradation of the 
48 kDa active fragment with an average repetitive 
yield of 98% established a single unambiguous e- 
quence as: 
Asn-Cys-Gly-Pro-Pro-Pro-Thr-Leu-Ser- 
Phe-Ala-Ala-Pro-Met-Asp-Ile-Thr-Leu- 
Thr-Glu 
where Cys is S-carboxamidomethylated cysteine. 
This amino acid sequence is identical to the N- 
terminal amino acid sequence of C4bp reported in 
171, indicating that the 48 kDa active fragment has 
been derived from the N-terminal portion of the 
parent 75 kDa subunit chain of C4bp. The 16th 
amino acid that has remained undetermined by the 
authors in [7] was identified as isoleucine. 
4. DISCUSSION 
Chymotryptic cleavage of C4bp revealed that 
each subunit chain of C4bp contained a specific 
peptide bond which located on a loop of the 
polypeptide chain cross-linked by a disulfide bond 
and was highly susceptible to chymotryptic 
cleavage. ~hymotrypsin rapidly cleaves this site 
and produces a nicked C4bp, composed of 
disulfide-linked 48 kDa and 27 kDa fragments. 
Subsequent slow cleavage on each 27 kDa frag- 
ment allows liberation of the 48 kDa active frag- 
ment from the nicked C4bp. It remains unknown 
whether a third cleavage also occurs on the 48 kDa 
fragment for the liberation of the 48 kDa fragment 
from the nicked C4bp. If the third cleavage does 
not occur on the 48 kDa fragment, the 48 kDa 
fragment released from the nicked C4bp will have 
a disulfide-linked 2 kDa fragment derived from 
the 27 kDa fragment. However, the purified 
48 kDa fragment gave a single unambiguous se- 
quence. So, it seems possible that a third cleavage 
occurs at the vicinity of the C-terminus of the 
48 kDa fragment and splits off a peptide fragment 
containing a cysteinyl residue through which the 
48 kDa fragment is linking to the 27 kDa frag- 
ment. SDS-PAGE of reduced samples also show- 
ed further cleavage of the 48 kDa fragment into a 
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43 kDa fragment upon prolonged incubation with 
chymotrypsin. 
The N-terminal amino acid sequence of the 
48 kDa active fragment was found to be identical 
to that of the parent subunit chain of C4bp. A 
possible gross structure of C4bp is shown in fig.3. 
Six or eight subunit chains of C4bp are cross- 
linked together by disulfide bonds at their C- 
terminal side to form a core domain, which would 
correspond to the central body observed by elec- 
tron microscopy [ 1 I]. Chymotrypsin sequentially 
splits at least two peptide bonds of each subunit 
chain and liberates an N-terminal derived 48 kDa 
fragment from each subunit chain of C4bp. The 
C4b-binding domain is located on the N-terminal 
derived 48 kDa fragment, while the carbohydrate 
chains are located on the C-terminal derived core 
domain [lo]. 
Authors in [ll] reported that C4b bound to the 
peripheral ends of the subunit chains of C4bp. It 
has been reported [7] that removal of the N- 
terminal 40 residue by trypsin did not affect the 
cofactor activity of C4bp. This result suggests that 
C4b-binding site would be located not at the N- 
terminus of each subunit chain but on a slightly in- 
ner portion from the N-terminal side. 
To characterize the C4b-binding domain in more 
detail, we are attempting to prepare lower 
molecular mass active fragments by further pro- 
teolysis of the 48 kDa active fragment. Although 
40 kDa and 25 kDa fragments were obtained by 
tryptic and chymotryptic cleavage of the 48 kDa 
fragment respectively, these fragments hardly 
showed cofactor activity (not shown). However, 
characterization of these fragments may provide 
valuable information concerning the critical region 
for cofactor activity, i.e., C4b-binding site, of 
C4bp. 
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